BioSpace News Archive

Jaguar Health, Inc. announced the voting results of the Company’s Special Meeting of Stockholders held on January 20, 2023 and announced that the Company will effect a reverse stock split of its issued and outstanding voting common stock, at an exchange ratio of 1-for-75, on Monday, January 23, 2023 in order to support the Company’s compliance with Nasdaq’s listing standards.

PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of disorders with intractable neurologic symptoms, today announced that it will be presenting virtually at the upcoming Virtual Investor Summit on January 26th.

Genexine (KOSDAQ: 095700) today announced it received Fast Track Designation (FTD) from the Korean Ministry of Food and Drug Safety (MFDS) for GX-188E (tirvalimogene teraplasmid), its first-in-class proprietary therapeutic DNA vaccine.

TELA Bio, Inc. announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of stock options to purchase an aggregate of 4,200 shares of its common stock and restricted stock units covering 7,250 shares of its common stock to 10 newly-hired employees, with a grant date of January 18, 2023.